Trials / Not Yet Recruiting
Not Yet RecruitingNCT05450770
Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination
The Yellow Fever Vaccine Immunity in HIV Infected Patients: Studies of Immunological Responses at 10 Years (ANRS 0146s NovaaTen)
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- ANRS, Emerging Infectious Diseases · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
ANRS 0146s NovaaTen study aims to determine the vaccine responses in the participants of the ANRS EP46 Novaa trial 10 years after a primary anti-yellow fever vaccination
Detailed description
The vaccine responses will be determined with the measurement of the neutralizing antibody titers using the neutralization tests PRNT and Pseudo type ACN 400 to M120 (ten years) in the participants of the ANRS EP 46 NOVAA trial, VIH+ and controls naïve to previous vaccination ten years after a primary anti-yellow fever vaccination.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Yellow fever vaccination (STAMARIL) | Yellow fever vaccination (STAMARIL) for HIV positive and negative subjects |
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2024-11-01
- Completion
- 2024-11-01
- First posted
- 2022-07-11
- Last updated
- 2024-07-30
Source: ClinicalTrials.gov record NCT05450770. Inclusion in this directory is not an endorsement.